Several novel series of C75 derivatives were synthesized and evaluated for their FAS inhibitory activities. The results showed compound 4-methylene-2-octyl-5-oxo-tetrahydro-thiophene-3-carboxylic acid (1c) had more effective FAS inhibitory (IC50 was 2.56 μM and T.I. was 9.26) and potent anti-tumor activities on HL60 and Hela cells in vitro (IC50 were 5.38 μM and 46.10 μM, respectively).
合成了几种新颖的C75衍
生物系列,并评估了它们的FAS抑制活性。结果表明,化合物4-亚甲基-2-辛基-5-氧代-
四氢噻吩-3-
羧酸(1c)具有更有效的FAS抑制作用(IC 50为2.56μM,TI为9.26),并具有较强的抗肿瘤活性。体外HL60和Hela细胞(IC 50分别为5.38μM和46.10μM)。